Tumor Immunotherapy Directed at PD-1

New England Journal of Medicine - United States
doi 10.1056/nejme1205943
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Inflammation Induced by Incomplete Radiofrequency Ablation Accelerates Tumor Progression and Hinders PD-1 Immunotherapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

PAK4 Inhibition Improves PD-1 Blockade Immunotherapy

Nature Cancer
2019English

Beyond PD-1 Immunotherapy in Malignant Melanoma

Dermatology and Therapy
Dermatology
2019English

Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

OS7 - 145 Combination Immunotherapy for Glioma: Beyond PD 1 Inhibition

Canadian Journal of Neurological Sciences
MedicineNeurology
2016English

The Role of PD-1/PD-L1 Axis in Treg Development and Function: Implications for Cancer Immunotherapy

OncoTargets and Therapy
OncologyPharmacology
2019English

Dynamic Metrics-Based Biomarkers to Predict Responders to Anti-Pd-1 Immunotherapy

British Journal of Cancer
Cancer ResearchOncology
2018English

ARID1A Alterations Function as a Biomarker for Longer Progression-Free Survival After Anti-Pd-1/Pd-L1 Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Tumor Regression at an Untreated Site During Immunotherapy of an Identical Distant Tumor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1975English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy